Share
1,146 Posts.
lightbulb Created with Sketch. 567
clock Created with Sketch. 23/06/21
15:31
Share
Originally posted by PigsMightFly:
↑
If you understood the company you would realise this "golden goose" is actually just the proof-of-concept disease that shows the amazing safety of the clinuvel drug and at the same time gathers data and gives authorities confidence in the company and what other diseases they can potentially treat. exactly the same as Epitan. This is where you are going to see the real BIG FARM OF GOLDEN GEESE when Clinuvel get approval for their existing drug to treat Vitiligo, XP, VP, OTRs (organ transplant recipients), skin cancer sufferers, Stroke victims (85% of 15 Million currently untreated) and with their OTC products for people who want solar protection and DNA repair - so pretty much everyone! one stroke patient. It will take another five years for the trials and approval process. The realistic chances of success are only 5-10%.new purpose will need separate clinical trials and approval. far easier to get Orphan Drug status. They have lower barriers for safety and efficacy and a much more streamlined approval process. Furthermore CUV is also very undervalued compared to comparison stocks like MSB, TLX and PNV who have similar or higher valuations despite not being profitable and just burning cash and they do not have the approvals that CUV has. nothing in common and can't be compared.
Expand
“CUV have treated one stroke patient. It will take another five years for the trials and approval process. The realistic chances of success are only 5-10%. ”
(20min delay)